New Rapid Genetic Test May Prevent Sepsis-Related Hearing Loss

Now, in a collaboration between Manchester-based geneticists and a molecular diagnostics company, a rapid test for distinguishing those infants who will have an adverse reaction to the antibiotic gentamicin has been developed.